- Home
- PDEX vs MCRB Comparison
PDEX vs MCRB Comparison
Compare PDEX & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDEX
- MCRB
- Stock Information
- Founded
- PDEX 1978
- MCRB 2010
- Country
- PDEX United States
- MCRB United States
- Employees
- PDEX N/A
- MCRB N/A
- Industry
- PDEX Medical/Dental Instruments
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- PDEX Health Care
- MCRB Health Care
- Exchange
- PDEX Nasdaq
- MCRB Nasdaq
- Market Cap
- PDEX 149.0M
- MCRB 125.7M
- IPO Year
- PDEX N/A
- MCRB 2015
- Fundamental
- Price
- PDEX $39.42
- MCRB $15.44
- Analyst Decision
- PDEX Strong Buy
- MCRB Hold
- Analyst Count
- PDEX 1
- MCRB 4
- Target Price
- PDEX $56.00
- MCRB $73.67
- AVG Volume (30 Days)
- PDEX 45.3K
- MCRB 125.1K
- Earning Date
- PDEX 09-04-2025
- MCRB 08-06-2025
- Dividend Yield
- PDEX N/A
- MCRB N/A
- EPS Growth
- PDEX 379.10
- MCRB N/A
- EPS
- PDEX 2.76
- MCRB 10.22
- Revenue
- PDEX $64,123,999.00
- MCRB N/A
- Revenue This Year
- PDEX $26.92
- MCRB N/A
- Revenue Next Year
- PDEX $4.48
- MCRB N/A
- P/E Ratio
- PDEX $14.16
- MCRB $1.51
- Revenue Growth
- PDEX 29.65
- MCRB N/A
- 52 Week Low
- PDEX $18.30
- MCRB $6.53
- 52 Week High
- PDEX $70.26
- MCRB $26.40
- Technical
- Relative Strength Index (RSI)
- PDEX 36.14
- MCRB 60.65
- Support Level
- PDEX $43.74
- MCRB $14.06
- Resistance Level
- PDEX $48.77
- MCRB $15.84
- Average True Range (ATR)
- PDEX 3.44
- MCRB 1.50
- MACD
- PDEX -1.19
- MCRB -0.04
- Stochastic Oscillator
- PDEX 16.68
- MCRB 86.35
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.